v3.26.1
Share-based Compensation (Tables)
3 Months Ended
Mar. 31, 2026
Share-based Compensation  
Schedule of share-based compensation expense

Three months ended March 31,

  ​ ​ ​

2026

  ​ ​ ​

2025

  ​ ​ ​

(in thousands)

Cost of sales

 

$

1,511

 

$

1,343

 

Research and development

2,506

3,048

Selling, general, and administrative

4,494

4,817

Total

$

8,511

$

9,208

Summary of non-vested restricted and performance shares activity

  ​ ​ ​

  ​ ​ ​

Weighted

Average

Number of

Grant Date

Shares

Fair Value

(in thousands)

Balance - December 31, 2025

2,551

$

28.89

Granted

1,113

30.79

Performance award adjustments

117

32.25

Vested

(942)

27.70

Forfeited

(32)

23.41

Balance - March 31, 2026

2,807

$

30.25